| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509842C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 07/08/2009 | CN100509837C Clone, expression and biological activity of stingray caudal spine cyclophilin A gene |
| 07/08/2009 | CN100509836C Clone, expression and biological activity of stingray tumor suppressor gene |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/08/2009 | CA2645701A1 Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same |
| 07/07/2009 | USRE40832 An adenovirus type 36 (Ad-36) vaccine formualtion suitable for administration to a patient for reducing cholesterol and triglyceride level ( cause of obesity); killed Ad-36, an inactivated Ad-36, a protein or peptide sequence including an Ad-36 coat protein or fragment |
| 07/07/2009 | US7557267 Expression vector comprising nucleotide sequences coding heat stable endopeptidase for use in generating heat resistance crop plants |
| 07/07/2009 | US7557264 Gossypium hirsutum tissue-specific promoters and their use |
| 07/07/2009 | US7557260 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch |
| 07/07/2009 | US7557259 Plastid transit peptides |
| 07/07/2009 | US7557204 CUDR as biomarker for cancer progression and therapeutic response |
| 07/07/2009 | US7557202 DNA fragments containing gene having function relating to autonomous proliferation of plasmid |
| 07/07/2009 | US7557200 Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation |
| 07/07/2009 | US7557197 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |
| 07/07/2009 | US7557196 Expression vector comprising nucleotide sequences granulocyte colony stimulating factor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/07/2009 | US7557195 granulocyte colony stimulating factor; provide a homogeneous product and a further purification process using the preparative column is not necessary; 1:1 molar ratio conjugates provide more improved stability and biological activity compared to G-CSF conjugates with several PEGs attached |
| 07/07/2009 | US7557194 Antibody materials for an IBD-associated polypeptide |
| 07/07/2009 | US7557192 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 07/07/2009 | US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 07/07/2009 | US7557186 Insecticidal proteins; treating insect infested plants; for generating disease resistant plants; biological pest control; insect resistance |
| 07/07/2009 | US7557185 Moraxella catarrhalis proteins |
| 07/07/2009 | US7557184 Isolated staphylococcus DNAX subunit and use thereof |
| 07/07/2009 | US7557183 Polyethylene glycol linked GLP-1 compounds |
| 07/07/2009 | US7557181 Pan-HER antagonists and methods of use |
| 07/07/2009 | US7557085 Via operably linked to Neuron Restrictive Silencing Element (NRSE) that is recognized by Neuron-Restrictive Silencing Factor (NRSF) transcriptional repressor, reducing nicotinamide adenine dinucleotide (NADH) concentrations in cell by inhibiting glycolytic enzymes such as hexokinase |
| 07/07/2009 | US7557084 IL-18 specific polypeptides and therapeutic uses thereof |
| 07/07/2009 | US7557083 Gastrokines and derived peptides including inhibitors |
| 07/07/2009 | US7557080 Bacillus Cry9 family members |
| 07/07/2009 | US7557079 Metalloprotease proteins |
| 07/07/2009 | US7557078 Morphogen-induced nerve regeneration and repair |
| 07/07/2009 | US7556969 Intensified neutral loss tags and use thereof in mass spectrometry |
| 07/07/2009 | US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 07/07/2009 | US7556964 Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals |
| 07/07/2009 | US7556963 Nucleotide sequences coding caspase for use in identifying modulators for treatment of allergies, cancer, and pathogenic infection |
| 07/07/2009 | US7556959 Polynucleotide encoding a polypeptide having a larvae growth inhibiting or insecticidal effect on Scarabaeidae insects |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556955 Nucleic acids encoding Candida kefyr cytosine deaminase |
| 07/07/2009 | US7556942 Genes in cancer and polynucleotides with codes for polypeptides with amino acid sequences |
| 07/07/2009 | US7556941 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 07/07/2009 | US7556940 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 07/07/2009 | US7556936 Insecticidal polypeptide for use in biological pest control; cry proteins |
| 07/07/2009 | US7556926 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 07/07/2009 | US7556925 Treating or preventing an alpha nu beta 3 integrin mediated disease or disorder; , imaging tissues using positron emission tomography or magnetic resonance imaging, assessing the metastatic characteristics of a tumor, and delivering DNA to a cell |
| 07/07/2009 | US7556920 Polypeptide that forms part of a ubiquitin-ligase complex involved in targeting proteins by ubiquitination for degradation by the proteasome; cancer (breast and prostate carcinoma), immune/inflammatory disease and neurological disease |
| 07/07/2009 | US7556816 Microbiocides, bactericides |
| 07/07/2009 | US7556815 Mutant viral antigen for use in diagnosing hepatitis; immunoassay |
| 07/07/2009 | US7556814 Antigen containing an attenuated strain of human immunodeficient virus; using psoralen and ultraviolet radiation |
| 07/07/2009 | US7556813 Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| 07/07/2009 | US7556812 Purified polypeptide used for eliciting immune response against a West Nile virus associated disease |
| 07/07/2009 | US7556811 Peptide epitopes of apolipoprotein B |
| 07/07/2009 | US7556809 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides |
| 07/07/2009 | US7556807 Streptococcus mutans competence stimulating peptide (CSP) which inhibits biofilm formation; dental carries, periodontal disease, gingivitis, and endocarditis; inhibiting dental plaque formation |
| 07/07/2009 | US7556806 High mannose oligosaccharide cluster used to induce an immune response for increasing production of 2G12 antibodies |
| 07/07/2009 | US7556805 Compositions for treatment of melanoma and method of using same |
| 07/07/2009 | CA2415990C Method for producing biologicals in protein-free culture |
| 07/07/2009 | CA2358227C Process for producing an amide compound |
| 07/07/2009 | CA2353909C Betacellulin muteins |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/07/2009 | CA2286098C Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 07/07/2009 | CA2215641C Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor |
| 07/07/2009 | CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/07/2009 | CA2168029C Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/07/2009 | CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 07/07/2009 | CA2158479C Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome |
| 07/03/2009 | CA2648406A1 Translocator component derivatives and uses thereof |
| 07/03/2009 | CA2618278A1 Ipac derivatives and uses thereof |
| 07/02/2009 | WO2009082664A2 Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof |
| 07/02/2009 | WO2009082647A2 Recombinant rift valley fever (rvf) viruses and methods of use |
| 07/02/2009 | WO2009082440A2 Compositions of toll-like receptor agonists and malaria antigens and methods of use |
| 07/02/2009 | WO2009082340A1 Method for monitoring the progression of fibrinolysis'646 |
| 07/02/2009 | WO2009082209A1 Improvement of the secretion yield of a protein of interest by in vivo proteolytic processing of a multimeric precursor |
| 07/02/2009 | WO2009081955A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 07/02/2009 | WO2009081440A2 Allergens and allergoids from bee venom |
| 07/02/2009 | WO2009081274A2 Mutant forms of streptolysin o |
| 07/02/2009 | WO2009081254A1 Cells belonging to the adaptive immune system that express paq isoform of tmem126b |
| 07/02/2009 | WO2009081170A2 Peptide fusion proteins |
| 07/02/2009 | WO2009081136A2 Screening |
| 07/02/2009 | WO2009081114A1 Fusion proteins comprising an slrp-derived anti-angiogenic sequence |
| 07/02/2009 | WO2009080852A1 Rplp1-based antitumour compounds |
| 07/02/2009 | WO2009080816A1 Fusion polypeptides comprising a shbg dimerization component and uses thereof |
| 07/02/2009 | WO2009080810A1 New polypeptides having affinity for her2 |
| 07/02/2009 | WO2009080806A2 Modified influenza virus |
| 07/02/2009 | WO2009080803A1 Vaccines for malaria |
| 07/02/2009 | WO2009080759A1 Organic compounds |
| 07/02/2009 | WO2009080608A1 Y2 receptor agonists |
| 07/02/2009 | WO2009080447A1 Edible product having an immunostimulating effect |
| 07/02/2009 | WO2009080302A1 Mhc rapid assay used for the customization of odours |
| 07/02/2009 | WO2009080054A1 Protease inhibitor |
| 07/02/2009 | WO2009080053A1 Efficient cell culture system for hepatitis c virus genotype 1a and 1b |
| 07/02/2009 | WO2009080052A1 Efficient cell culture system for hepatitis c virus genotype 6a |
| 07/02/2009 | WO2009079911A1 Pegylated erythropoietin conjugate and preparation method and uses thereof |
| 07/02/2009 | WO2009079910A1 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof |
| 07/02/2009 | WO2009079834A1 An anti-hcv vaccine and preparation methods and uses thereof |
| 07/02/2009 | WO2009079796A1 Recombinant rsv antigens |
| 07/02/2009 | WO2009079790A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | WO2009079775A1 Composition for supporting heat shock protein function comprising glutamine |
| 07/02/2009 | WO2009079762A1 Diagnostic test for cardiomyopathy |
| 07/02/2009 | WO2009079693A1 Design and selection of medicaments that modulate the function and activity of interleukin 13 |